We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Analytik Jena CEO Klaus Berka Becomes an Advisor of the Fraunhofer IZI
News

Analytik Jena CEO Klaus Berka Becomes an Advisor of the Fraunhofer IZI

Analytik Jena CEO Klaus Berka Becomes an Advisor of the Fraunhofer IZI
News

Analytik Jena CEO Klaus Berka Becomes an Advisor of the Fraunhofer IZI

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Analytik Jena CEO Klaus Berka Becomes an Advisor of the Fraunhofer IZI"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The CEO of Analytik Jena AG, Klaus Berka, has been appointed to the Advisory Board of the Fraunhofer Institute for Cell Therapy and Immunology (IZI).

Fraunhofer IZI, which was founded in Leipzig in 2005, researches and develops solutions to specific problems at the interfaces between medicine, life sciences, and engineering, such as drugs, cell therapy, diagnostics, and biobanks.

"I am pleased that I will have the opportunity as a member of this select board to help see to it that the institute can successfully and effectively continue its work in important pharmaceutical and therapeutic areas. I hope that I will be able to substantively enrich the work of the Advisory Board with my experience," Klaus Berka said. "Communication between science and business has been a very important personal concern of mine for many years."

In its Life Science business unit, Analytik Jena develops instruments, kits, and reagents in the area of biotechnology and molecular diagnostics that address a rapidly growing global market.

Advertisement